AbbVie
ABBV
#28
Rank
C$545.96 B
Marketcap
C$308.91
Share price
-0.06%
Change (1 day)
27.07%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of September 2025 : -C$3.61 Billion

According to AbbVie's latest financial reports the company has -C$3.61 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$4.82 B-64.99%
2023-12-31$C$13.79 B-41.21%
2022-12-31$C$23.45 B19.24%
2021-12-31$C$19.67 B17.8%
2020-12-31$C$16.69 B-256.46%
2019-12-31$-C$10.68 Billion-7.23%
2018-12-31$-C$11.51 Billion-279.54%
2017-12-31$C$6.40 B2.86%
2016-12-31$C$6.23 B13.84%
2015-12-31$C$5.47 B170.71%
2014-12-31$C$2.02 B-57.72%
2013-12-31$C$4.78 B42.99%
2012-12-31$C$3.34 B-72.45%
2011-12-31$C$12.13 B-22.68%
2010-12-31$C$15.69 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
C$128.96 B-3,681.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$25.76 B-815.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$33.04 B-1,017.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$13.32 B-470.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$29.72 B-925.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$25.22 B-800.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$29.33 B-914.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
C$63.68 B-1,868.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$4.16 B-215.57%๐Ÿ‡บ๐Ÿ‡ธ USA